E3 Ligase Inhibitors
The present invention provides, e.g., compounds having the structure of formula (I): The present invention also provides pharmaceutical compositions that include such compounds, and methods for modulating murine double minute 2 protein (Mdm2) E3 ligase activity, particularly the Mdm2-MdmX hetero-complex E3 ligase activity, using such compounds.
Attached files:Patents:WO 2,010,107,485
Inventor(s):
STOCKWELL BRENT R [US]; HERMAN ARIEL [US]
Type of Offer:
Licensing
« More Pharmaceutical Patents